Dantron
 | |
 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral, rectal (enema) |
| ATC code | |
| Identifiers | |
| |
JSmol) | |
| Density | 1.575 g/cm3 g/cm3 |
| |
| |
  (what is this?) (verify) | |
Dantron (
.It should not be confused with ondansetron, an unrelated drug that was marketed in South Africa under the trade name "Dantron".
Medical uses
In the USA, dantron is not used because it is considered to be a carcinogen.[2]
In the
opioids. Its British Approved Name was danthron, but it has now been changed to "dantron", the recommended International Nonproprietary Name.[3]
Dantron can be administered orally, or can be administered rectally as an enema either in combination with other laxatives or alone.[4]
Side effects
Dantron has the notable side-effect of causing red-colored urine.
See also
References
- .
- ^ "Danthron substance profile" (PDF). National Toxicology Program.
- ^ British National Formulary website (requires free registration)
- ^ "A06AG Enemas". WHO Collaborating Centre for Drug Statistics Methodology. World Health Organization. 13 December 2018. Retrieved 17 March 2019.